Mycophenolate Mofetil | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Mycophenolate Mofetil
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Mycophenolate Mofetil

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 29 USDMF, 18 CEP/COS, 2 JDMF, 8 EU WC, 9 KDMF, 17 NDC API, 27 Listed Suppliers, $ API Reference Price

50 API Suppliers
29 USDMF
18 CEP/COS
2 JDMF
8 EU WC
9 KDMF
17 NDC API
27 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

19 Drugs in Development

19 Drugs in Development

FINISHED DOSAGE FORMULATIONS

162 FDF Dossiers, 45 FDA Orange Book, 60 Europe, 16 Canada, 13 South Africa, 28 Listed Dossiers

162 FDF Dossiers
45 FDA Orange Book
60 Europe
16 Canada
13 South Africa
28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 250MG, TABLET;ORAL - 500MG, FOR SUSPENSION;ORAL - 200MG/ML

CAPSULE;ORAL - 250MG
TABLET;ORAL - 500MG
FOR SUSPENSION;ORAL - 200MG/ML

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 17 DKSH, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 26 BASF, 2 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 25 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 33 Controlled & Modified Release, 30 Thickeners and Stabilizers, 26 Solubilizers, 24 Film Formers & Plasticizers, 21 Topical, 20 Direct Compression, 19 Disintegrants & Superdisintegrants, 19 Granulation, 17 Parenteral, 17 Lubricants & Glidants, 14 Taste Masking, 13 Co-Processed Excipients, 9 Empty Capsules, 9 Emulsifying Agents, 9 Chewable & Orodispersible Aids, 8 API Stability Enhancers, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

61 Fillers, Diluents & Binders
56 Coating Systems & Additives
33 Controlled & Modified Release
30 Thickeners and Stabilizers
26 Solubilizers
24 Film Formers & Plasticizers
21 Topical
20 Direct Compression
19 Disintegrants & Superdisintegrants
19 Granulation
17 Parenteral
17 Lubricants & Glidants
14 Taste Masking
13 Co-Processed Excipients
9 Empty Capsules
9 Emulsifying Agents
9 Chewable & Orodispersible Aids
8 API Stability Enhancers
7 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

21 NEWS #PharmaBuzz

21 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 55 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
55 Finished Drug Prices
10 Annual Reports

MARKET PLACE

13 APIs, 8 FDF Dossiers

13 APIs
8 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 6 Health Canada Patents

3 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 4 Others

2 EDQM
3 USP
4 Others

$ API Ref.Price (USD/KG) : 177 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3AZURITY

filter Patent Number Reset all filters

3 All

01 111931455

02 112097284

03 112097285

filter API Patent Reset all filters

3 All

01 3Blank

filter FDF Patent Reset all filters

3 All

01 3Y

filter Expiration Date Reset all filters

3 All

01 32039-08-16

Product Main Page

01

AZURITY

MYCOPHENOLATE MOFETIL

BioAsia

Not Confirmed

AZURITY

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-16

MYCOPHENOLATE MOFETIL

US Patent Number : 12097285

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216482

Patent Use Code : U-1752

Delist Requested :

Patent Use Description : PROPHYLAXIS OF ORGAN R...

Patent Expiration Date : 2039-08-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AZURITY

MYCOPHENOLATE MOFETIL

BioAsia

Not Confirmed

AZURITY

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-16

MYCOPHENOLATE MOFETIL

US Patent Number : 11931455

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216482

Patent Use Code : U-1752

Delist Requested :

Patent Use Description : PROPHYLAXIS OF ORGAN R...

Patent Expiration Date : 2039-08-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AZURITY

MYCOPHENOLATE MOFETIL

BioAsia

Not Confirmed

AZURITY

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-16

MYCOPHENOLATE MOFETIL

US Patent Number : 12097284

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216482

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!